Comparison between the aggregation of human and rodent amyloid β-proteins in GM1 ganglioside clusters

Biochemistry

Volumn 53, Issue 48, 2014, Pages 7523-7530

  Ueno, Hiroshi ^a   Yamaguchi, Takahiro ^a   Fukunaga, Saori ^a   Okada, Yuki ^a   Yano, Yoshiaki ^a   Hoshino, Masaru ^a   Matsuzaki, Katsumi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZO DYES; CYTOLOGY; DEPOSITION; GLYCOPROTEINS; MAMMALS; NEURODEGENERATIVE DISEASES; PATHOLOGY;

ALZHEIMER'S DISEASE; AMYLOID BETAS; AMYLOID DEPOSITION; AMYLOID FIBRIL; AMYLOIDOGENESIS; BUFFER SOLUTIONS; MODEL MEMBRANES; PATHOLOGIC CONDITIONS;

PROTEINS;

AMYLOID BETA PROTEIN; BUFFER; CONGO RED; GANGLIOSIDE; GANGLIOSIDE GM1; AMYLOID;

ALZHEIMER DISEASE; ARTICLE; ARTIFICIAL MEMBRANE; CELL MEMBRANE; COMPARATIVE STUDY; HUMAN; HUMAN CELL; NERVE CELL; NEUROBLASTOMA CELL LINE; NONHUMAN; PROTEIN AGGREGATION; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL; CELL LINE; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; INFRARED SPECTROSCOPY; METABOLISM; MOLECULAR GENETICS; MOUSE; PATHOLOGY; PROTEIN MULTIMERIZATION; PROTEIN SECONDARY STRUCTURE; RAT; SPECIES DIFFERENCE; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

RODENTIA;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; AMYLOID; AMYLOID BETA-PEPTIDES; ANIMALS; CELL LINE; CELL SURVIVAL; G(M1) GANGLIOSIDE; HUMANS; MEMBRANE MICRODOMAINS; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NEURONS; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, SECONDARY; RATS; SPECIES SPECIFICITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 84916219015     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi501239q     Document Type: Article

References (57)

1. Hardy, J., and Selkoe, D. J. (2002) The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297, 353-356.
2. Walsh, D. M., and Selkoe, D. J. (2004) Deciphering the molecular basis of memory failure in Alzheimer' s disease. Neuron 44, 181-193.
3. Masters, C. L., and Selkoe, D. J. (2012) Biochemistry of amyloid β-protein and amyloid deposits in Alzheimer disease. Cold Spring Harbor Perspect. Med. 2, a006262.
4. Selkoe, D. J. (2011) Resolving controversies on the path to Alzheimer's therapeutics. Nat. Med. 17, 1060-1065.
5. Selkoe, D. J. (1989) Biochemistry of altered brain proteins in Alzheimer's disease. Annu. Rev. Neurosci. 12, 463-490.
6. Bush, A. I. (2003) The metallobiology of Alzheimer 's disease. Trends Neurosci. 26, 207-214.
7. Bush, A. I., Pettingell, W. H., Multhaup, G., d Paradis, M., Vonsattel, J. P., Gusella, J. F., Beyreuther, K., Masters, C. L., and Tanzi, R. E. (1994) Rapid induction of Alzheimer Aβ amyloid formation by zinc. Science 265, 1464-1467.
8. Atwood, C. S., Moir, R. D., Huang, X., Scarpa, R. C., Bacarra, N. M., Romano, D. M., Hartshorn, M. A., Tanzi, R. E., and Bush, A. I. (1998) Dramatic aggregation of Alzheimer Aβ by Cu(II) is induced by conditions representing physiological acidosis. J. Biol. Chem. 273, 12817-12826.
9. Liu, S. T., Howlett, G., and Barrow, C. J. (1999) Histidine-13 is a crucial residue in the zinc ion-induced aggregation of the Aβ peptide of Alzheimer's disease. Biochemistry 38, 9373-9378.
10. Lau, T.-L., Ambroggio, E. E., Tew, D. J., Cappi, R., Masters, C. L., Fidelio, G. D., Barnham, K. J., and Separovic, F. (2006) Amyloid-β peptide disruption of lipid membranes and the effect of metal ions. J. Mol. Biol. 356, 759-770.
11. Matsuzaki, K. (2007) Physicochemical interactions of amyloid β-peptide with lipid bilayers. Biochim. Biophys. Acta 1768, 1935-1942.
12. Matsuzaki, K., Kato, K., and Yanagisawa, K. (2010) Aβ polymerization through interaction with membrane gangliosides. Biochim. Biophys. Acta 1801, 868-877.
13. Matsuzaki, K. (2011) Formation of toxic amyloid fibrils by amyloid β-protein on ganglioside clusters. International Journal of Alzheimer' s Research 2011, ID 956104.
14. Matsuzaki, K. (2014) How do membranes initiate Alzheimer's disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters. Acc. Chem. Res. 47, 2397-2404.
15. Yanagisawa, K., Odaka, A., Suzuki, N., and Ihara, Y. (1995) GM1 ganglioside-bound amyloid β-protein (Aβ): A possible form of preamyloid in Alzheimer's disease. Nat. Med. 1, 1062-1066.
16. Kakio, A., Nishimoto, S., Yanagisawa, K., Kozutsumi, Y., and Matsuzaki, K. (2001) Cholesterol-dependent formation of GM1 ganglioside-bound amyloid β-protein, an endogenous seed for Alzheimer amyloid. J. Biol. Chem. 276, 24985-24990.
17. Ikeda, K., Yamaguchi, T., Fukunaga, S., Hoshino, M., and Matsuzaki, K. (2011) Mechanism of amyloid β-protein aggregation mediated by GM1 ganglioside clusters. Biochemistry 50, 6433-6440.
18. Okada, T., Ikeda, K., Wakabayashi, M., Ogawa, M., and Matsuzaki, K. (2008) Formation of toxic Aβ (1-40) fibrils on GM1 ganglioside-containing membranes mimicking lipid rafts: Polymorphisms in Aβ (1-40) fibrils. J. Mol. Biol. 382, 1066-1074.
19. Fukunaga, S., Ueno, H., Yamaguchi, T., Yano, Y., Hoshino, M., and Matsuzaki, K. (2012) GM1 cluster mediates formation of toxic Aβ fibrils by providing hydrophobic environments. Biochemistry 51, 8125-8131.
20. Lee, E. K., Hwang, J. H., Shin, D. Y., Kim, D. I., and Yoo, Y. J. (2005) Production of recombinant amyloid-β peptide 42 as an ubiquitin extension. Protein Expression Purif. 40, 183-189.
21. Yamaguchi, T., Yagi, H., Goto, Y., Matsuzaki, K., and Hoshino, M. (2010) A disulfide-linked amyloid-β peptide dimer forms a protofibril-like oligomer through a distinct pathway from amyloid fibril formation. Biochemistry 49, 7100-7107.
22. Okada, T., Wakabayashi, M., Ikeda, K., and Matsuzaki, K. (2007) Formation of toxic fibrils of Alzheimer's amyloid β-protein-(1-40) by monosialoganglioside GM1, a neuronal membrane component. J. Mol. Biol. 371, 481-489.
23. Yamamoto, N., Matsuzaki, K., and Yanagisawa, K. (2005) Cross-seeding of wild-type and hereditary variant type amyloid β-proteins in the presence of gangliosides. J. Neurochem. 95, 1167-1176.
24. Svennerholm, L. (1957) Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method. Biochim. Biophys. Acta 24, 604-611.
25. Ogawa, M., Tsukuda, M., Yamaguchi, T., Ikeda, K., Okada, T., Yano, Y., Hoshino, M., and Matsuzaki, K. (2011) Ganglioside-mediated aggregation of amyloid β-proteins (Aβ): Comparison between Aβ-(1-42) and Aβ-(1-40). J. Neurochem. 116, 851-857.
26. LeVine, H., III (1993) Thioflavin T interaction with synthetic Alzheimer's disease β-amyloid peptides: Detection of amyloid aggregation in solution. Protein Sci. 2, 404-410.
27. Naiki, H., and Gejyo, F. (1999) Kinetic analysis of amyloid fibril formation. Methods Enzymol. 309, 305-318.
28. Surewicz, W. K., and Mantsch, H. H. (1989) The conformation of dynorphin A-(1-13) in aqueous solution as studied by Fourier transform infrared spectroscopy. J. Mol. Struct. 214, 143-147.
29. Miyazawa, T. (1960) Perturbation treatment of the characteristic vibrations of polypeptide chains in various configurations. J. Chem. Phys. 32, 1647-1652.
30. Miyazawa, T., and Blout, E. R. (1961) The infrared spectra of polypeptides in various conformations: Amide I and II bands. J. Am. Chem. Soc. 83, 712-719.
31. Jackson, M., and Mantsch, H. H. (1995) The use and misuse of FTIR spectroscopy in the determination of protein structure. Crit. Rev. Biochem. Mol. Biol. 30, 95-120.
32. Khurana, R., and Fink, A. L. (2000) Do parallel β-helix proteins have a unique Fourier transform infrared spectrum? Biophys. J. 78, 994-1000.
33. Selkoe, D. J., Bell, D. S., Podlisny, M. B., Price, D. L., and Cork, L. C. (1987) Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease. Science 235, 873-877.
34. Philipson, O., Lord, A., Gumucio, A., O'Callaghan, P., Lannfelt, L., and Nilsson, L. N. (2010) Animal models of amyloid-β-related pathologies in Alzheimer's disease. FEBS J. 277, 1389-1409.
35. Chambon, C., Wegener, N., Gravius, A., and Danysz, W. (2011) Behavioural and cellular effects of exogenous amyloid-β peptides in rodents. Behav. Brain Res. 225, 623-641.
36. Nanga, R. P., Brender, J. R., Xu, J., Hartman, K., Subramanian, V., and Ramamoorthy, A. (2009) Three-dimensional structure and orientation of rat islet amyloid polypeptide protein in a membrane environment by solution NMR spectroscopy. J. Am. Chem. Soc. 131, 8252-8261.
37. Brender, J. R., Salamekh, S., and Ramamoorthy, A. (2012) Membrane disruption and early events in the aggregation of the diabetes related peptide IAPP from a molecular perspective. Acc. Chem. Res. 45, 454-462.
38. Williamson, M. P., Suzuki, Y., Bourne, N. T., and Asakura, T. (2006) Binding of amyloid β-peptide to ganglioside micelles is dependent on histidine-13. Biochem. J. 397, 483-490.
39. Coles, M., Bicknell, W., Watson, A. A., Fairlie, D. P., and Craik, D. J. (1998) Solution structure of amyloid β-peptide(1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is? Biochemistry 37, 11064-11077.
40. Shao, H., Jao, S.-C., Ma, K., and Zagorski, M. G. (1999) Solution structure of micelle-bound amyloid β-(1-40) and β-(1-42) peptides of Alzheimer' s disease. J. Mol. Biol. 285, 755-773.
41. Jarvet, J., Danielsson, J., Damberg, P., Oleszczuk, M., and Graslund, A. (2007) Positioning of the Alzheimer Aβ (1-40) peptide in SDS micelles using NMR and paramagnetic probes. J. Biomol. NMR 39, 63-72.
42. Utsumi, M., Yamaguchi, Y., Sasakawa, H., Yamamoto, N., Yanagisawa, K., and Kato, K. (2008) Up-and-down topological mode of amyloid β-peptide lying on hydrophilic/hydrophobic interface of ganglioside clusters. Glycoconjugate J. 26, 999-1006.
43. Wakabayashi, M., and Matsuzaki, K. (2007) Formation of amyloids by Aβ-(1-42) on NGF-differentiated PC12 cells: Roles of gangliosides and cholesterol. J. Mol. Biol. 371, 924-933.
44. Klunk, W. E., Pettegrew, J. W., and Abraham, D. J. (1989) Quantitative evaluation of Congo red binding to amyloid-like proteins with a β-pleated sheet conformation. J. Histochem. Cytochem. 37, 1273-1281.
45. Biancalana, M., and Koide, S. (2010) Molecular mechanism of Thioflavin-T binding to amyloid fibrils. Biochim. Biophys. Acta 1804, 1405-1412.
46. Berthelot, K., Ta, H. P., Géan, J., Lecomte, S., and Cullin, C. (2011) In vivo and in vitro analyses of toxic mutants of HET-s: FTIR antiparallel signature correlates with amyloid toxicity. J. Mol. Biol. 412, 137-152.
47. Stroud, J. C., Liu, C., Teng, P. K., and Eisenberg, D. (2012) Toxic fibrillar oligomers of amyloid-β have cross-β structure. Proc. Natl. Acad. Sci. U.S.A. 109, 7717-7722.
48. Law, A., Gauthier, S., and Quirion, R. (2001) Say NO to Alzheimer's disease: The putative links between nitric oxide and dementia of the Alzheimer's type. Brain Res. Rev. 35, 73-96.
49. Igbavboa, U., Avdulov, N. A., Schroeder, F., and Wood, W. G. (1996) Increasing age alters transbilayer fluidity and cholesterol asymmetry in synaptic plasma membranes in mice. J. Neurochem. 66, 1717-1725.
50. Hayashi, H., Igbavboa, U., Hamanaka, H., Kobayashi, M., Fujita, S. C., Wood, W. G., and Yanagisawa, K. (2002) Cholesterol is increased in the exofacial leaflet of synaptic plasma membranes of human apolipoprotein E4 knock-in mice. NeuroReport 13, 383-386.
51. Yamamoto, N., Matsubara, T., Sato, T., and Yanagisawa, K. (2008) Age-dependent high-density clustering of GM1 ganglioside at presynaptic neuritic terminals promotes amyloid β-protein fibrillogenesis. Biochim. Biophys. Acta 1778, 2717-2726.
52. Bugiani, O., Giaccone, G., Verga, L., Pollo, B., Ghetti, B., Frangione, B., and Tagliavini, F. (1990) Alzheimer patients and Down patients: Abnormal presynaptic terminals are related to cerebral preamyloid deposits. Neurosci. Lett. 119, 56-59.
53. Probst, A., Langui, D., Ipsen, S., Robakis, N., and Ulrich, J. (1991) Deposition of β/A4 protein along neuronal plasma membranes in diffuse senile plaques. Acta Neuropathol. 83, 21-29.
54. Yamamoto, N., Hirabayashi, Y., Amari, M., Yamaguchi, H., Romanov, G., Van Nostrand, W. E., and Yanagisawa, K. (2005) Assembly of hereditary amyloid β-protein variants in the presence of favorable gangliosides. FEBS Lett. 579, 2185-2190.
55. Yamamoto, N., Van Nostrand, W. E., and Yanagisawa, K. (2006) Further evidence of local ganglioside-dependent amyloid β-protein assembly in brain. NeuroReport 17, 1735-1737.
56. Hayashi, H., Kimura, N., Yamaguchi, H., Hasegawa, K., Yokoseki, T., Shibata, M., Yamamoto, N., Michikawa, M., Yoshikawa, Y., Terao, K., Matsuzaki, K., Lemere, C. A., Selkoe, D. J., Naiki, H., and Yanagisawa, K. (2004) A seed for Alzheimer amyloid in the brain. J. Neurosci. 24, 4894-4902.
57. Yamamoto, N., Yokoseki, T., Shibata, M., Yamaguchi, H., and Yanagisawa, K. (2005) Suppression of Aβ deposition in brain by peripheral administration of Fab fragments of anti-seed antibody. Biochem. Biophys. Res. Commun. 335, 45-47.